OBJECTIVE: To estimate the rate of new chronic benzodiazepine use after hospitalization in older adults not previously prescribed with benzodiazepines. DESIGN: Retrospective cohort study using linked, population-based administrative data. SETTING: Ontario, Canada between April 1, 1992 and March 31, 2005. PARTICIPANTS: Community-dwelling seniors who had not been prescribed benzodiazepine drugs in the year before hospitalization were selected from all 1.4 million Ontario residents aged 66 years and older. MAIN OUTCOME MEASURES: New chronic benzodiazepine users, defined as initiation of benzodiazepines within 7 days after hospital discharge and an additional claim within 8 days to 6 months. We used multivariate logistic regression to examine for the effect of hospitalization on the primary outcome after adjusting for confounders. RESULTS: There were 405,128 patient hospitalizations included in the cohort. Benzodiazepines were prescribed to 12,484 (3.1%) patients within 7 days of being discharged from hospital. A total of 6,136 (1.5%) patients were identified as new chronic benzodiazepine users. The rate of new chronic benzodiazepine users decreased over the study period from 1.8% in the first year to 1.2% in the final year (P < .001). Multivariate logistic regression found that women, patients admitted to the intensive care unit or nonsurgical wards, those with longer hospital stays, higher overall comorbidity, a prior diagnosis of alcoholism, and those prescribed more medications had significantly elevated adjusted odds ratios for new chronic benzodiazepine users. Older individuals had a lower risk for the primary outcome. CONCLUSION: New benzodiazepine prescription after hospitalization occurs frequently in older adults and may result in chronic use. A systemic effort to address this risky practice should be considered.
OBJECTIVE: To estimate the rate of new chronic benzodiazepine use after hospitalization in older adults not previously prescribed with benzodiazepines. DESIGN: Retrospective cohort study using linked, population-based administrative data. SETTING: Ontario, Canada between April 1, 1992 and March 31, 2005. PARTICIPANTS: Community-dwelling seniors who had not been prescribed benzodiazepine drugs in the year before hospitalization were selected from all 1.4 million Ontario residents aged 66 years and older. MAIN OUTCOME MEASURES: New chronic benzodiazepine users, defined as initiation of benzodiazepines within 7 days after hospital discharge and an additional claim within 8 days to 6 months. We used multivariate logistic regression to examine for the effect of hospitalization on the primary outcome after adjusting for confounders. RESULTS: There were 405,128 patient hospitalizations included in the cohort. Benzodiazepines were prescribed to 12,484 (3.1%) patients within 7 days of being discharged from hospital. A total of 6,136 (1.5%) patients were identified as new chronic benzodiazepine users. The rate of new chronic benzodiazepine users decreased over the study period from 1.8% in the first year to 1.2% in the final year (P < .001). Multivariate logistic regression found that women, patients admitted to the intensive care unit or nonsurgical wards, those with longer hospital stays, higher overall comorbidity, a prior diagnosis of alcoholism, and those prescribed more medications had significantly elevated adjusted odds ratios for new chronic benzodiazepine users. Older individuals had a lower risk for the primary outcome. CONCLUSION: New benzodiazepine prescription after hospitalization occurs frequently in older adults and may result in chronic use. A systemic effort to address this risky practice should be considered.
Authors: Anita K Wagner; Dennis Ross-Degnan; Jerry H Gurwitz; Fang Zhang; Daniel B Gilden; Leon Cosler; Stephen B Soumerai Journal: Ann Intern Med Date: 2007-01-16 Impact factor: 25.391
Authors: R C Oude Voshaar; W J M J Gorgels; A J J Mol; A J L M van Balkom; E H van de Lisdonk; M H M Breteler; H J M van den Hoogen; F G Zitman Journal: Br J Psychiatry Date: 2003-06 Impact factor: 9.319
Authors: Anita K Wagner; Stephen B Soumerai; Fang Zhang; Connie Mah; Linda Simoni-Wastila; Leon Cosler; Thomas Fanning; Peter Gallagher; Dennis Ross-Degnan Journal: Int J Qual Health Care Date: 2003-10 Impact factor: 2.038
Authors: Annemie Somers; Hugo Robays; Kurt Audenaert; Georges Van Maele; Marc Bogaert; Mirko Petrovic Journal: Eur J Clin Pharmacol Date: 2011-01-29 Impact factor: 2.953
Authors: Nicholas T Vozoris; Hadas D Fischer; Xuesong Wang; Geoffrey M Anderson; Chaim M Bell; Andrea S Gershon; Anne L Stephenson; Sudeep S Gill; Paula A Rochon Journal: Drugs Aging Date: 2013-03 Impact factor: 3.923
Authors: Nicholas T Vozoris; Xuesong Wang; Hadas D Fischer; Andrea S Gershon; Chaim M Bell; Sudeep S Gill; Denis E O'Donnell; Peter C Austin; Anne L Stephenson; Paula A Rochon Journal: Br J Clin Pharmacol Date: 2015-10-02 Impact factor: 4.335
Authors: Damon C Scales; Hadas D Fischer; Ping Li; Arlene S Bierman; Olavo Fernandes; Muhammad Mamdani; Paula Rochon; David R Urbach; Chaim M Bell Journal: J Gen Intern Med Date: 2016-02 Impact factor: 5.128